Paul R. Gielen

Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function

Paul R. Gielen, Barbara M. Schulte, Esther D. Kers‐Rebel et al. · Neuro-Oncology · 2016 · 160 citations · Full text

Increase in Both CD14-Positive and CD15-Positive Myeloid-Derived Suppressor Cell Subpopulations in the Blood of Patients With Glioma But Predominance of CD15-Positive Myeloid-Derived Suppressor Cells in Glioma Tissue

Paul R. Gielen, Barbara M. Schulte, Esther D. Kers‐Rebel et al. · Journal of Neuropathology & Experimental Neurology · 2015 · 120 citations · Full text

Immunology, Blood Cell, Pathology +19

Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway

Paul R. Gielen, Qurratulain Aftab, Noreen Ma et al. · Neuropharmacology · 2013 · 116 citations

Glioma, Mitochondrial Function, Mitochondrial Apoptosis Pathway +8

Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma

Michiel Kroesen, Christian Büll, Paul R. Gielen et al. · OncoImmunology · 2016 · 62 citations · Full text

Tumor Innervation, Immunology, Nbl Cells +20

Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma

Kim C. M. Santegoets, Paul R. Gielen, Christian Büll et al. · Cancer Immunology Immunotherapy · 2019 · 44 citations · Full text